Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
CADL holding history
Candel Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CADL overviewAll 13F holders of CADLFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −12,780−100.0% | Sold out | Holders |
| Q1 2026 | 12,780 | $62.6K | <0.1% | +12,780 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −163,600−100.0% | Sold out | Holders |
| Q2 2025 | 163,600 | $827.8K | <0.1% | +163,600 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −20,600−100.0% | Sold out | Holders |
| Q2 2024 | 20,600 | $127.7K | <0.1% | −36,305−63.8% | Reduced | Holders |
| Q1 2024 | 56,905 | $90.0K | <0.1% | +38,230+204.7% | Added | Holders |
| Q4 2023 | 18,675 | $27.0K | <0.1% | +18,675 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −12,800−100.0% | Sold out | Holders |
| Q2 2023 | 12,800 | $16.0K | <0.1% | −8,200−39.0% | Reduced | Holders |
| Q1 2023 | 21,000 | $28.0K | <0.1% | +21,000 | New | Holders |